Noliprel Arg (Indapamide, Perindopril Arginine)

Perindopril blocks the angiotensin‑converting enzyme, reducing angiotensin II levels and causing blood vessels to relax. Indapamide promotes the excretion of sodium and water through the kidneys, decreasing plasma volume. Together they provide a complementary reduction in vascular resistance and blood volume, resulting in lower blood pressure.

The dosage of Noliprel Arg is individualized by the prescribing clinician based on the patient’s blood pressure, renal function, and overall health status. The prescriber determines the appropriate strength and frequency, and patients should follow the written prescription without alteration.

Safety of Noliprel Arg in pregnancy or lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To request Noliprel Arg, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑component ACE inhibitors or thiazide diuretics, Noliprel Arg offers a combined mechanism that can achieve greater blood‑pressure reduction at lower individual doses, potentially improving tolerability. However, the choice of therapy depends on patient‑specific factors, comorbidities and physician judgment.

Noliprel Arg tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

The medication is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water; do not crush, chew, or split the tablet unless specifically instructed.

Serious adverse reactions include angioedema (swelling of the face, lips, tongue, or airway), severe hypotension, acute kidney injury, and hyperkalemia. Patients should seek immediate medical attention if they experience any signs of swelling, rapid heartbeat, faintness, or marked changes in urine output.

Noliprel Arg is contraindicated in patients with a known hypersensitivity to indapamide, perindopril, or any component of the formulation, as well as those with a history of angioedema related to ACE‑inhibitor therapy. It should also be avoided in individuals with severe renal impairment or hyperkalemia unless closely monitored.